Best Hospitals for Testicular cancer treatment in Spain 2024

Dr. Antonio Alcaraz heads the Department of Urology and kidney transplantation at Teknon Medical Center (Barcelona, Spain). Dr. Antonio Alcaraz is a leading Spanish surgeon, uro-oncologist, and transplantologist with more than 30 years of experience. Under his management over 500 successful operations have been conducted for the treatment of pathologies of the urogenital system. A lot of surgical interventions have been made by minimally invasive methods (including laparoscopic transvaginal kidney removal, nephrectomy, and renal transplantation). The Antonio’s Alcaraz prior specialty is the treatment of prostate cancer. Treatment of oncological diseases of kidneys, bladder, adrenal glands, testicles, ureters and other organs of the genitourinary system is provided by traditional surgical methods and innovative ones on Da Vinci robotic system. Dr. Antonio Alcaraz also treats congenital pathologies in children, e.g. cryptorchism. The Doctor is a member of such authoritative specialized communities: American Urological Confederation; Urological Association of Spain; European Urological Society.

Academic Education:Bachelor of Medicine and Surgery. University of Barcelona.Doctor in medicine. University of Barcelona. Extraordinary prize for doctoral thesis.Training in translational research thanks to a post-doctoral stay at Memorial Sloan-Kettering Cancer Center (New York, USA).Professional Experience:Medical Oncologist specialized in urological cancer. Her areas of expertise are prostate cancer, kidney, bladder and urinary tract cancer, and testicular cancer.She currently works as a Senior Consultant in the Medical Oncology Service of the Hospital Clínic de Barcelona, ​​where she is responsible for urological cancer. At HM Delfos, from Medical Oncology, she is responsible for the care of patients with urological cancer, from a multidisciplinary approach in coordination with the different specialists (urology, radiotherapy, pathology) through joint work and the Tumor Committee. She is also responsible for the introduction of new therapies and the development of clinical trial projects in this area.Scientific and Teaching Activity:Associate Professor of the Faculty of Medicine of the Clinical Hospital. University of Barcelona. Teaching in the subject of Medical Oncology, of the 5th year of the Degree in Medicine and Surgery at the University of Barcelona. She has been the director of several Final Degree projects for medical students in ​​urological cancer.Teacher and Director of the subject "Prostate Cancer" of the Master of Biomedicine. University of Barcelona.Teacher and Director of the subject "Comprehensive management of the uro-oncological patient", of the Master of Uro-Oncology of Advanced Medical Competences. University of Barcelona. Direction of several doctoral theses on prostate cancer.Extensive experience in the training of Residents in Medical Oncology at the Clinical Hospital de Barcelona.Extensive teaching experience in scientific courses and symposiums.Internship tutor for students of the Master in Art Therapy at Escuela Metáfora. Art therapy in cancer patients at Hospital Clinic.Coordinator of Mindfulness training workshops in Oncology.Clinical research:   Extensive experience as principal investigator of multiple clinical trials, phase I, II and III, of new therapies in urological cancer.Translational research: Researcher at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS). Leader of the Prostate Cancer working group, within the Translational Genomics Laboratory and Targeted Therapy in Solid Tumors. Her fundamental line of research is based on the investigation of resistance mechanisms to prostate cancer treatments and the study of biomarkers that allow progress towards personalized medicine in this disease.She has published more than 140 scientific articles in international journals.Areas of Professional Interest:Her interest as a professional is to provide the best care for patients with urological cancer from all areas: the best care on an individual basis and offer them the best available treatment or the possibility of having access to new treatments within clinical trials. In addition, she has a great interest in promoting comprehensive care for patients and their families.